NCT07101406

Brief Summary

The aim of this clinical trial was to examine the effects of the Turkish Nutrition Guide Recommendations Diet and the DASH Diet on blood sugar, blood pressure, and biochemical parameters in patients with gestational diabetes. The study hypotheses are as follows: Hypothesis 1: The DASH diet reduces fasting blood glucose levels more in patients with gestational diabetes compared to a diet adapted to a healthy diet specific to Türkiye. Hypothesis 1: The DASH diet reduces insulin levels more in patients with gestational diabetes compared to a diet adapted to a healthy diet specific to Turkey. Hypothesis 1: The DASH diet reduces HbA1c levels more in patients with gestational diabetes compared to a diet adapted to a healthy diet specific to Türkiye. Hypothesis 1: The Dash diet reduces 1st-hour postprandial glucose levels more significantly in women with gestational diabetes compared to a diet adapted to a healthy diet typical of Türkiye. Participants: After being diagnosed with gestational diabetes by a doctor using an OGTT test at 24-28 weeks, the researcher will complete a general information form during their first consultation with the dietitian. For four weeks, the dietitian will follow the diets created by the researcher based on their assigned diet group in a blinded manner. They will record their fasting and postprandial blood sugar levels in the morning, noon, evening, night, and during snacks, if they are taking them. They will keep a 24-hour food consumption record before meeting with the researcher weekly. Participants will have their biochemical parameters assessed at the beginning of the study and at the end of the fourth week.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 24, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
Last Updated

August 7, 2025

Status Verified

August 1, 2025

Enrollment Period

12 months

First QC Date

July 24, 2025

Last Update Submit

August 2, 2025

Conditions

Keywords

gestational diabetesdash dietTürkiye Nutrition Guidediet

Outcome Measures

Primary Outcomes (1)

  • Change in fasting blood glucose levels

    To monitor daily fasting blood glucose levels (mg/dL) using a glucometer throughout the 4-week intervention.

    Daily for 4 weeks

Secondary Outcomes (7)

  • Change in 1-hour postprandial blood glucose levels

    Daily for 4 weeks

  • Change in fasting insulin level

    Baseline and Week 4

  • Change in daily energy and nutrient intake based on 24-Hour Food Consumption Record

    Baseline and weekly over 4 weeks

  • Change in lipid profile (total cholesterol, HDL-C, LDL-C, triglycerides)

    Baseline and Week 4

  • Change in iron-related parameters (iron, ferritin, total iron-binding capacity)

    Baseline and Week 4

  • +2 more secondary outcomes

Study Arms (2)

Active Comparator: Türkiye Nutrition Guideline Diet Group

ACTIVE COMPARATOR

Participants followed a diet based on the Türkiye Nutrition Guideline (TÜBER) for pregnancy. The diet consisted of 45-60% carbohydrates, 12-20% protein (minimum 70 g), and 20-35% fat. Portion sizes were explained during the initial consultation. Participants recorded their food intake weekly and attended weekly follow-up visits for anthropometric and blood pressure measurements. Diets were adjusted weekly based on blood glucose levels.

Other: Türkiye Nutrition Guideline Diet

Active Comparator: DASH Diet Group

ACTIVE COMPARATOR

Participants followed a diet based on the Dietary Approaches to Stop Hypertension (DASH) guidelines. The diet consisted of 45-60% carbohydrates (minimum 175 g), 12-20% protein (minimum 70 g), and 20-35% fat including 6% saturated fat and 150 mg cholesterol. It was low in sodium (2300 mg/day) and rich in potassium (4700 mg), calcium (1250 mg), and magnesium (500 mg). It emphasized low-fat dairy, lean meats, 10 servings/day of fruits and vegetables, and 4-5 servings/week of nuts, seeds, and legumes. Weekly follow-ups were conducted as in the other group.

Other: DASH Diet

Interventions

A diet structured according to the Türkiye Nutrition Guideline (TÜBER) for pregnant women, consisting of 45-60% carbohydrates, 12-20% protein (minimum 70 g), and 20-35% fat. Diets were tailored weekly based on blood glucose levels and individual dietary intake records.

Active Comparator: Türkiye Nutrition Guideline Diet Group

A dietary plan based on DASH guidelines: 45-60% carbohydrates (≥175 g), 12-20% protein (≥70 g), 20-35% fat (≤6% saturated), ≤2300 mg sodium, ≥4700 mg potassium, ≥1250 mg calcium, ≥500 mg magnesium. Includes low-fat dairy, lean meats, fruits/vegetables, and nuts/seeds.

Active Comparator: DASH Diet Group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female participants aged 18 to 35 years
  • Singleton pregnancy
  • Clinical diagnosis of gestational diabetes mellitus (GDM)
  • Ability to use a glucometer

You may not qualify if:

  • Pre-gestational diabetes or impaired glucose tolerance (IGT)
  • Hypoglycemia
  • Receiving insulin therapy
  • Development of preeclampsia
  • Failure to adhere to the prescribed diet
  • Smoking
  • Alcohol consumption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atlas Univercity Hospital

Istanbul, Bagcılar, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes, Gestational

Interventions

Dietary Approaches To Stop Hypertension

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized single-blind. Participants were blinded.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Asisstant (Dietitian)

Study Record Dates

First Submitted

July 24, 2025

First Posted

August 3, 2025

Study Start

June 1, 2024

Primary Completion

May 20, 2025

Study Completion

July 22, 2025

Last Updated

August 7, 2025

Record last verified: 2025-08

Locations